Daniel A. Heller

Daniel A. Heller is a biomedical engineer and Researcher at the Molecular Pharmacology Program of Memorial Sloan Kettering Cancer Center (MSKCC). He leads the Cancer Nanotechnology Laboratory, focusing on nanotechnologies for cancer diagnosis and treatment. Heller earned his PhD from the University of Illinois at Urbana-Champaign and has been affiliated with institutions such as the Georgia Institute of Technology.

Research Interests: Heller’s work spans Biomedical Engineering and Nanotechnology, with key applications in Cancer Research, Drug Delivery Systems, and Biosensors. He explores the use of Artificial Intelligence in diagnostics, particularly for diseases like ovarian cancer and brain tumors, and investigates the safety and chemistry of carbon nanotubes.

Publications Trends: His recent contributions include advancements in Carbon Nanotubes for biomedical imaging and drug delivery, machine learning-driven biosensors, and nanocarrier technologies to overcome the blood-brain barrier. Notable collaborations include co-editing the Handbook of Carbon Nanomaterials (2025).

Scientific Awards:

• College of Liberal Arts and Sciences Young Alumni Award (2024)
• Life Sciences Invention of the Year (2023)
• AIMBE Fellow (2021)
• NSF CAREER Award (2018)
• NIH Director’s New Innovator Award (2012)

Advising & Collaborations: Heller has mentored numerous PhD students and postdoctoral researchers across institutions like MSKCC, Weill Cornell, and Georgia Tech. His lab affiliates with programs such as the Tri-Institutional PhD Program in Chemical Biology and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences.